Compare VLRS & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VLRS | LENZ |
|---|---|---|
| Founded | 2005 | 2019 |
| Country | Mexico | United States |
| Employees | 6901 | N/A |
| Industry | Air Freight/Delivery Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 823.2M | 278.4M |
| IPO Year | N/A | 2021 |
| Metric | VLRS | LENZ |
|---|---|---|
| Price | $7.11 | $7.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $9.16 | ★ $44.00 |
| AVG Volume (30 Days) | 412.3K | ★ 820.2K |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,088,000.00 |
| Revenue This Year | $13.96 | $50.42 |
| Revenue Next Year | $12.62 | $197.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.17 | $6.83 |
| 52 Week High | $10.80 | $50.19 |
| Indicator | VLRS | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 41.51 | 33.18 |
| Support Level | $6.88 | N/A |
| Resistance Level | $7.50 | $10.34 |
| Average True Range (ATR) | 0.25 | 0.62 |
| MACD | -0.02 | -0.12 |
| Stochastic Oscillator | 7.55 | 18.67 |
Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.